Back to Journals » Cancer Management and Research » Volume 16
Original Research
The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
603 | Dovepress* | 603+ | 21 | 624 | |
Totals | 603 | 21 | 624 | ||
*Since 8 August 2024 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 2 | 0 | 2 |
View citations on PubMed and Google Scholar